﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Tabriz University of Medical Sciences</PublisherName>
      <JournalTitle>BioImpacts</JournalTitle>
      <Issn>2228-5652</Issn>
      <Volume>13</Volume>
      <Issue>5</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2023</Year>
        <Month>09</Month>
        <DAY>01</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Epigenetics of the blood pressure reactivity to salt: Is the salt sensitive phenotype correctable?</ArticleTitle>
    <FirstPage>355</FirstPage>
    <LastPage>358</LastPage>
    <ELocationID EIdType="doi">10.34172/bi.2023.27552</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Luigi X</FirstName>
        <LastName>Cubeddu</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-0154-6342</Identifier>
      </Author>
    </AuthorList>
    <PublicationType>EDITORIAL</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.34172/bi.2023.27552</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2022</Year>
        <Month>07</Month>
        <Day>29</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2022</Year>
        <Month>12</Month>
        <Day>15</Day>
      </PubDate>
    </History>
    <Abstract>Salt sensitivity defines a state characterized by a highly reactive blood pressure to changes in salt intake. The salt-sensitive phenotype is strongly associated with hypertension, visceral adiposity/metabolic syndrome, and ageing. Obesity accounts for around 70% of hypertension in young adults, and 30% to 50% of adult hypertensives carry the salt-sensitive phenotype. It is estimated that the salt-sensitive phenotype is responsible for high blood pressure in over 600 million adults. But is the salt-sensitive phenotype correctable? Interventional, controlled, clinical trials in obese adolescents and young obese adults, demonstrated that weight-reducing lifestyle modifications revert the salt-sensitive to the salt-resistant phenotype, and restored the faulty production of nitric oxide. Correction of the salt-sensitive phenotype lowers the blood pressure by reducing its reactivity to dietary salt. In a random sample of obese adults subjected to lifestyle modifications, those who were salt-resistant at baseline, were also normotensive and failed to further lower their blood pressure despite a 12% drop in body weight. The salt-resistant phenotype protects the metabolically healthy obese from hypertension, even if their salt consumption is comparable to that of salt-sensitive obese. In summary, at early stages, the elevated blood pressure of obesity, is determined by epigenetic changes leading to a state of salt-sensitivity.</Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Salt sensitivity</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Blood pressure</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Obesity</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>